Publication: Antimicrobial properties of a potential probiotic lactobacillus from thai newborn feces
0
0
Issued Date
2015
Resource Type
File Type
application/pdf
ISSN
1252208
Other identifier(s)
2-s2.0-84957628214
Rights Holder(s)
Scopus
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol 98, (2015), p.S116-S122
Suggested Citation
Chimchang J., Theparee T., Ladda B., Tanasupawat S., Wongsatayanon B.T., Taweechotipatr M. Antimicrobial properties of a potential probiotic lactobacillus from thai newborn feces. Journal of the Medical Association of Thailand. Vol 98, (2015), p.S116-S122. Retrieved from: https://hdl.handle.net/20.500.14740/6071
Abstract
Background: Probiotics are increasingly used to treat infectious diarrhea and antibiotic-associated diarrhea. Many probiotic bacteria are classified in general such as Lactobacillus and are able to colonize the gastrointestinal tracts of infants. Objective: This study was performed to detect antimicrobial substances and activity in 200 Lactobacillus isolates obtained from healthy Thai newborn feces. Material and Method: Reuterin production was detected by the spot overlay technique and colorimetric assay. Antimicrobial activity was tested by using a well diffusion, agar method. Results: Lactobacillus strain MSMC64-1 produced reuterin and demonstrated potent antimicrobial activity against seven pathogenic indicator strains with very strong inhibitory activities against Salmonella typhi DMST 5784 and methicillin resistant Staphylococcus aureus (MRSA) DMST 20651. There was strong inhibitory activity against methicillin resistant Staphylococcus aureus (MRSA) DMST 20654, Vibrio parahaemolyticus DMST 5665 and Shigella dysenteriae DMST 15111. There was moderate to weak inhibitory activities against Vibrio cholerae DMST 2873 and Helicobacter pylori (H40). The Lactobacillus strain MSMC 64-1 showed resistance to acidic pH (pH 2, 3, 4) and tolerance to 1%, 2%, 3%, and 4% bile concentrations. Sequencing of the 16S ribosomal DNA identified the candidate’s strain as Lactobacillus reuteri with 98% sequence homology. Conclusion: The active isolate could potentially be used as a probiotic to prevent and treat enteric infections. © 2015, Medical Association of Thailand. All rights reserved.
Subject(s)
DNA 16S
Probiotic agent
Reuterin
Unclassified drug
3-hydroxypropionaldehyde
Antiinfective agent
Glyceraldehyde
Probiotic agent
Propane
Agar diffusion
Antibacterial activity
Antimicrobial activity
Article
Bacterium identification
Bacterium isolation
Colorimetry
Controlled study
Escherichia coli
Feces analysis
Growth inhibition
Helicobacter pylori
Human
Intestine infection
Lactobacillus
Lactobacillus reuteri
Methicillin resistant Staphylococcus aureus
Microbiological examination
Newborn
Nonhuman
Polymerase chain reaction
Salmonella enterica serovar Typhi
Shigella dysenteriae
Spot overlay technique
Thailand
Vibrio cholerae
Vibrio parahaemolyticus
Analogs and derivatives
Drug effects
Feces
Gastrointestinal tract
Isolation and purification
Lactobacillus
Male
Microbiology
Anti-Infective Agents
Feces
Gastrointestinal Tract
Glyceraldehyde
Humans
Infant, Newborn
Lactobacillus
Male
Methicillin-Resistant Staphylococcus aureus
Probiotics
Propane
Probiotic agent
Reuterin
Unclassified drug
3-hydroxypropionaldehyde
Antiinfective agent
Glyceraldehyde
Probiotic agent
Propane
Agar diffusion
Antibacterial activity
Antimicrobial activity
Article
Bacterium identification
Bacterium isolation
Colorimetry
Controlled study
Escherichia coli
Feces analysis
Growth inhibition
Helicobacter pylori
Human
Intestine infection
Lactobacillus
Lactobacillus reuteri
Methicillin resistant Staphylococcus aureus
Microbiological examination
Newborn
Nonhuman
Polymerase chain reaction
Salmonella enterica serovar Typhi
Shigella dysenteriae
Spot overlay technique
Thailand
Vibrio cholerae
Vibrio parahaemolyticus
Analogs and derivatives
Drug effects
Feces
Gastrointestinal tract
Isolation and purification
Lactobacillus
Male
Microbiology
Anti-Infective Agents
Feces
Gastrointestinal Tract
Glyceraldehyde
Humans
Infant, Newborn
Lactobacillus
Male
Methicillin-Resistant Staphylococcus aureus
Probiotics
Propane
